Silvia McColl Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$757K Hold
2,895
– – 0.45% 52
2026
Q2
$728K Sell
2,895
-18
-0.6% -$3.87K 0.44% 55
2026
Q1
$634K Hold
2,913
– – 0.42% 55
2025
Q4
$666K Hold
2,913
– – 0.44% 52
2025
Q3
$674K Hold
2,913
– – 0.46% 51
2025
Q2
$541K Hold
2,913
– – 0.39% 62
2025
Q1
$610K Hold
2,913
– – 0.46% 50
2024
Q4
$518K Sell
2,913
-207
-7% -$38.1K 0.39% 61
2024
Q3
$616K Hold
3,120
– – 0.46% 51
2024
Q2
$535K Hold
3,120
– – 0.44% 50
2024
Q1
$527K Buy
3,120
+66
+2% +$11.4K 0.45% 53
2023
Q4
$473K Hold
3,054
– – 0.43% 57
2023
Q3
$455K Hold
3,054
– – 0.46% 54
2023
Q2
$411K Hold
3,054
– – 0.38% 61
2023
Q1
$487K Sell
3,054
-99
-3% -$15.1K 0.48% 51
2022
Q4
$510K Buy
+3,153
New +$483K 0.5% 50

Other funds holding ABBV

Silvia McColl Wealth Management's ABBV Position: Q3 2026 in Review

Silvia McColl Wealth Management held its AbbVie (ABBV) position steady in Q3 2026 at 2,895 shares worth $757K. The position accounts for 0.45% of the portfolio, ranked #52.

Silvia McColl Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Silvia McColl Wealth Management held 2,895 shares of AbbVie worth $757K as of Q3 2026.
  • Silvia McColl Wealth Management left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.45% of Silvia McColl Wealth Management's portfolio in Q3 2026, its #52 holding.
  • Silvia McColl Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Silvia McColl Wealth Management's 13F filing for Q3 2026, filed 7 Oct 2026.